BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group.
Read more about us >
As a Corporate partner in the Bird & Bird Life Sciences team in Paris, I mainly advise innovative companies financed by venture capital, in particular biotech/medtech, digital health, and wellness companies.
French Healthtech in the Covid crisis: when strategic issues lead to growth
The strategic challenges of the French Healthtech sector - health, innovation, sovereignty - are undeniably...
October 13, 2020
6 min read
Sofia El Biyed
The allocation of BSPCEs (Bons de Souscription de Parts de Créateurs d’Entreprise) to independent board directors: a small revolution for joint stock companies, a real breakthrough for the biotech world
Biotech and medtech companies operate in an international environment where the composition of their...
October 30, 2019
2 min read